Tumor-infiltrating myeloid cells (TIMs) comprise monocytes, macrophages, dendritic cells, and neutrophils, and have emerged as key regulators of cancer growth. These cells can diversify into a spectrum of states, which might promote or limit tumor outgrowth but remain poorly understood. Here, we used single-cell RNA sequencing (scRNA-seq) to map TIMs in non-small-cell lung cancer patients. We uncovered 25 TIM states, most of which were reproducibly found across patients. To facilitate translational research of these populations, we also profiled TIMs in mice. In comparing TIMs across species, we identified a near-complete congruence of population structures among dendritic cells and monocytes; conserved neutrophil subsets; and species diffe...
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Lung adenocarcinoma (LUAD) harboring EGFR mutations prevails in Asian population. However, the inter...
BackgroundTumor infiltrating myeloid (TIM) cells constitute a vital element of the tumor microenviro...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of myeloid c...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Immunotherapy has revolutionized the treatment of several human cancers, including non-small cell lu...
Immunotherapy has revolutionized the treatment of several human cancers, including non-small cell lu...
Cancer cells are embedded in the tumor microenvironment (TME), a complex ecosystem of stromal cells....
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Lung adenocarcinoma (LUAD) harboring EGFR mutations prevails in Asian population. However, the inter...
BackgroundTumor infiltrating myeloid (TIM) cells constitute a vital element of the tumor microenviro...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of myeloid c...
Abstract The tumor immune microenvironment (TIME) is commonly infiltrated by diverse collections of ...
Immunotherapy has revolutionized the treatment of several human cancers, including non-small cell lu...
Immunotherapy has revolutionized the treatment of several human cancers, including non-small cell lu...
Cancer cells are embedded in the tumor microenvironment (TME), a complex ecosystem of stromal cells....
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Glioblastomas are aggressive primary brain cancers that recur as therapy-resistant tumors. Myeloid c...
Lung adenocarcinoma (LUAD) harboring EGFR mutations prevails in Asian population. However, the inter...